152 related articles for article (PubMed ID: 32432845)
21. Continuous infusion vs intermittent vancomycin in neurosurgical intensive care unit patients.
Hong LT; Goolsby TA; Sherman DS; Mueller SW; Reynolds P; Cava L; Neumann R; Kiser TH
J Crit Care; 2015 Oct; 30(5):1153.e1-6. PubMed ID: 26239323
[TBL] [Abstract][Full Text] [Related]
22. A rapid and simple UPLC method for serum vancomycin determination in pediatric patients undergoing continuous infusion or intermittent infusion of vancomycin.
Zhang M; Huang X; Yahui W; Shi C; Pei P; Yang J; Dong Q; Cui X
J Pharm Biomed Anal; 2019 Sep; 174():214-219. PubMed ID: 31176931
[TBL] [Abstract][Full Text] [Related]
23. Intermittent vs. continuous vancomycin infusion for gram-positive infections: A systematic review and meta-analysis.
Chu Y; Luo Y; Quan X; Jiang M; Zhou B
J Infect Public Health; 2020 Apr; 13(4):591-597. PubMed ID: 31530441
[TBL] [Abstract][Full Text] [Related]
24. Importance of vancomycin loading doses in intermittent infusion regimens.
Šíma M; Hartinger J; Cikánková T; Slanař O
J Infect Chemother; 2018 Apr; 24(4):247-250. PubMed ID: 29195829
[TBL] [Abstract][Full Text] [Related]
25. Continuous infusion versus intermittent infusion vancomycin in a burn center intensive care unit.
Schlobohm CJ; Zhu E; Duby JJ
Burns; 2021 Nov; 47(7):1495-1501. PubMed ID: 34538672
[TBL] [Abstract][Full Text] [Related]
26. Population Pharmacokinetics and Pharmacodynamic Target Attainment of Vancomycin in Neonates on Extracorporeal Life Support.
Cies JJ; Moore WS; Nichols K; Knoderer CA; Carella DM; Chopra A
Pediatr Crit Care Med; 2017 Oct; 18(10):977-985. PubMed ID: 28650363
[TBL] [Abstract][Full Text] [Related]
27. Therapeutic drug monitoring-guided continuous infusion of piperacillin/tazobactam significantly improves pharmacokinetic target attainment in critically ill patients: a retrospective analysis of four years of clinical experience.
Richter DC; Frey O; Röhr A; Roberts JA; Köberer A; Fuchs T; Papadimas N; Heinzel-Gutenbrunner M; Brenner T; Lichtenstern C; Weigand MA; Brinkmann A
Infection; 2019 Dec; 47(6):1001-1011. PubMed ID: 31473974
[TBL] [Abstract][Full Text] [Related]
28. Factors associated with inadequate early vancomycin levels in critically ill patients treated with continuous infusion.
De Waele JJ; Danneels I; Depuydt P; Decruyenaere J; Bourgeois M; Hoste E
Int J Antimicrob Agents; 2013 May; 41(5):434-8. PubMed ID: 23410793
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of a pediatric continuous-infusion vancomycin therapy guideline.
McKamy S; Chen T; Lee M; Ambrose PJ
Am J Health Syst Pharm; 2012 Dec; 69(23):2066-71. PubMed ID: 23172265
[TBL] [Abstract][Full Text] [Related]
30. Optimisation of vancomycin exposure in neonates based on the best level of evidence.
Dao K; Guidi M; André P; Giannoni E; Basterrechea S; Zhao W; Fuchs A; Pfister M; Buclin T; Csajka C
Pharmacol Res; 2020 Apr; 154():104278. PubMed ID: 31108184
[TBL] [Abstract][Full Text] [Related]
31. The Effectiveness of a Vancomycin Dosing Guideline in the Neonatal Intensive Care Unit for Achieving Goal Therapeutic Trough Concentrations.
Reilly AM; Ding MX; Rower JE; Kiser TH
J Clin Pharmacol; 2019 Jul; 59(7):997-1005. PubMed ID: 30776089
[TBL] [Abstract][Full Text] [Related]
32. [Level of evidence for therapeutic drug monitoring of vancomycin].
Jelassi ML; Benlmouden A; Lefeuvre S; Mainardi JL; Billaud EM;
Therapie; 2011; 66(1):29-37. PubMed ID: 21466775
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of a Pilot Vancomycin Precision Dosing Advisory Service on Target Exposure Attainment Using an Interrupted Time Series Analysis.
Stocker SL; Carland JE; Reuter SE; Stacy AE; Schaffer AL; Stefani M; Lau C; Kirubakaran R; Yang JJ; Shen CFJ; Roberts DM; Marriott DJE; Day RO; Brett J
Clin Pharmacol Ther; 2021 Jan; 109(1):212-221. PubMed ID: 33190285
[TBL] [Abstract][Full Text] [Related]
34. Comparison of bactericidal activities of intermittent and continuous infusion dosing of vancomycin against methicillin-resistant Staphylococcus aureus and Enterococcus faecalis.
Klepser ME; Patel KB; Nicolau DP; Quintiliani R; Nightingale CH
Pharmacotherapy; 1998; 18(5):1069-74. PubMed ID: 9758317
[TBL] [Abstract][Full Text] [Related]
35. Vancomycin penetration of uninfected pleural fluid exudate after continuous or intermittent infusion.
Byl B; Jacobs F; Wallemacq P; Rossi C; de Francquen P; Cappello M; Leal T; Thys JP
Antimicrob Agents Chemother; 2003 Jun; 47(6):2015-7. PubMed ID: 12760889
[TBL] [Abstract][Full Text] [Related]
36. Vancomycin dosing in critically ill trauma patients: The VANCTIC Study.
Villanueva RD; Talledo O; Neely S; White B; Celii A; Cross A; Kennedy R
J Trauma Acute Care Surg; 2019 Nov; 87(5):1164-1171. PubMed ID: 31464871
[TBL] [Abstract][Full Text] [Related]
37. Clinical Utility and Safety of a Model-Based Patient-Tailored Dose of Vancomycin in Neonates.
Leroux S; Jacqz-Aigrain E; Biran V; Lopez E; Madeleneau D; Wallon C; Zana-Taïeb E; Virlouvet AL; Rioualen S; Zhao W
Antimicrob Agents Chemother; 2016 Apr; 60(4):2039-42. PubMed ID: 26787690
[TBL] [Abstract][Full Text] [Related]
38. Comparison of conventional dosing versus continuous-infusion vancomycin therapy for patients with suspected or documented gram-positive infections.
James JK; Palmer SM; Levine DP; Rybak MJ
Antimicrob Agents Chemother; 1996 Mar; 40(3):696-700. PubMed ID: 8851595
[TBL] [Abstract][Full Text] [Related]
39. Vancomycin intermittent dosing versus continuous infusion for treatment of ventilator-associated pneumonia in trauma patients.
Schmelzer TM; Christmas AB; Norton HJ; Heniford BT; Sing RF
Am Surg; 2013 Nov; 79(11):1185-90. PubMed ID: 24165255
[TBL] [Abstract][Full Text] [Related]
40. Monitoring of vancomycin serum levels for the treatment of staphylococcal infections.
Kitzis MD; Goldstein FW
Clin Microbiol Infect; 2006 Jan; 12(1):92-5. PubMed ID: 16460555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
